Cabaletta Bio Stock (NASDAQ: CABA) stock price, news, charts, stock research, profile.
You can purchase shares of Cabaletta Bio (NASDAQ:CABA) through any online brokerage.
Other companies in Cabaletta Bio’s space includes: Macrogenics (NASDAQ:MGNX), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), Zentalis Pharma (NASDAQ:ZNTL) and Atossa Therapeutics (NASDAQ:ATOS).
Cabaletta Bio has a consensus price target of $26.85.
The stock price for Cabaletta Bio (NASDAQ: CABA) is $4.37 last updated October 4, 2024 at 4:04 PM EDT.
There are no upcoming dividends for Cabaletta Bio.
Cabaletta Bio’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Cabaletta Bio.
Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.